PHAT vs MSFT: Which Stock is Better?
Side-by-side comparison of Phathom Pharmaceuticals Inc and Microsoft Corp in 2026
PHAT
Phathom Pharmaceuticals Inc
$13.19
MSFT
Microsoft Corp
$430.11
Key Metrics Comparison
| Metric | PHAT | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.00B | N/A | PHAT |
| P/E Ratio | N/A | 26.32 | MSFT |
| EPS (TTM) | $N/A | $15.97 | MSFT |
| Revenue Growth | 0.9% | 0.2% | PHAT |
| Gross Margin | 87.1% | 68.6% | PHAT |
Analyze PHAT
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAT or MSFT a better investment?
Comparing PHAT and MSFT: Phathom Pharmaceuticals Inc has a market cap of $1.00B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAT and MSFT?
PHAT (Phathom Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAT or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAT or MSFT?
PHAT has higher revenue growth at 0.9% vs 0.2% for MSFT.
Which company is more profitable: PHAT or MSFT?
Phathom Pharmaceuticals Inc (PHAT) has higher gross margins at 87.1% compared to 68.6% for MSFT.
Which is the larger company: PHAT or MSFT?
Phathom Pharmaceuticals Inc (PHAT) is larger with a market cap of $1.00B compared to N/A for MSFT.
Should I buy PHAT or MSFT in 2026?
Both PHAT and MSFT have investment merit. PHAT trades at $13.19 while MSFT trades at $430.11. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAT and MSFT stock?
Key differences: Market Cap ($1.00B vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (0.9% vs 0.2%), Gross Margin (87.1% vs 68.6%).